Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Preclinical and clinical results with Virulizin in pancreatic cancer presented at AACR meeting

April 12, 1999

LeukoSite and Ilex hold pre-BLA meeting with FDA

April 12, 1999

GVAX prostate cancer vaccine enters additional phase I/II trial

April 9, 1999

NeoPharm to collaborate with NCI on cytotoxic cancer ligand

April 9, 1999

Progress with AltaRex's AIT products for cancer

April 8, 1999

M-Vax cancer vaccine granted orphan drug designation

April 6, 1999

Antisoma's Theragyn granted orphan drug status in the U.S.

April 6, 1999

DSMB completes interim evaluation of Maxamine phase III clinical trials

April 1, 1999

Reanalysis of data attributes greater efficacy to Multikine

March 30, 1999

Procyon receives Canadian patent for PSP94

March 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...